Sex difference in survival of patients treated by surgical resection for esophageal cancer

World Journal of Surgery

Volumn 31, Issue 10, 2007, Pages 1982-1987

  Hidaka, Hideki ^a   Hotokezaka, Masayuki ^a   Nakashima, Shinya ^a   Uchiyama, Shuichiro ^a   Maehara, Naoki ^a   Chijiiwa, Kazuo ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CIGARETTE SMOKING; ESOPHAGUS CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; POSTOPERATIVE COMPLICATION; PROGNOSIS; SEX DIFFERENCE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASMS, SQUAMOUS CELL; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEX FACTORS; SMOKING; SURVIVAL ANALYSIS;

EID: 34548699148     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-007-9193-1     Document Type: Article

References (33)

1. Hesketh PJ, Clapp RW, Doos WG, et al. (1989) The increasing frequency of adenocarcinoma of the esophagus. Cancer 64:526-530
2. Pera M, Cameron AJ, Trastek VF, et al. (1993) Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 104:510-513
3. Matsuo K, Hamajima N, Shinoda M, et al. (2001) Gene-environment interaction between an aldehyde dehydrogenase-2 (ALDH2) polymorphism and alcohol consumption for the risk of esophageal cancer. Carcinogenesis 22:913-916
4. Yokoyama A, Muramatsu T, Ohmori T, et al. (1998) Alcohol-related cancers and aldehyde dehydrogenase-2 in Japanese alcoholics. Carcinogenesis 19:1383-1387
5. Castellsague X, Munoz N, De Stefani E, et al. (1999) Independent and joint effects of tobacco smoking and alcohol drinking on the risk of esophageal cancer in men and women. Int J Cancer 82:657-664
6. Tavani A, Negri E, Franceschi S, et al. (1994) Risk factors for esophageal cancer in lifelong nonsmokers. Cancer Epidemiol Biomarkers Prev 3:387-392
7. Anonymous (1986) IARC Monographs programme on the evaluation of the carcinogenic risk of chemicals to humans: preamble. IARC Monogr Eval Carcinog Risk Chem Hum 39:13-32
8. Sakata K, Hoshiyama Y, Morioka S, et al. (2005) Smoking, alcohol drinking and esophageal cancer: findings from the JACC Study. J Epidemiol 15(Suppl 2):S212-219
9. Angele MK, Schwacha MG, Ayala A, et al. (2000) Effect of gender and sex hormones on immune responses following shock. Shock 14:81-90
10. Zellweger R, Wichmann MW, Ayala A, et al. (1997) Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males. Crit Care Med 25:106-110
11. Bone RC (1992) Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). JAMA 268:3452-3455
12. Majetschak M, Christensen B, Obertacke U, et al. (2000) Sex differences in posttraumatic cytokine release of endotoxin-stimulated whole blood: relationship to the development of severe sepsis. J Trauma 48:832-839; discussion 839-840
13. Kovacs EJ, Messingham KA, Gregory MS (2002) Estrogen regulation of immune responses after injury. Mol Cell Endocrinol 193:129-135
14. Wichmann MW, Zellweger R, DeMaso CM, et al. (1996) Mechanism of immunosuppression in males following trauma-hemorrhage: critical role of testosterone. Arch Surg 131:1186-1191; discussion 1191-1182
15. Salo M (1992) Effects of anaesthesia and surgery on the immune response. Acta Anaesthesiol Scand 36:201-220
16. Shigemitsu Y, Saito T, Kinoshita T, et al. (1992) Influence of surgical stress on bactericidal activity of neutrophils and complications of infection in patients with esophageal cancer. J Surg Oncol 50:90-97
17. Wichmann MW, Muller C, Hornung HM, et al. (2001) Gender differences in long-term survival of patients with colorectal cancer. Br J Surg 88:1092-1098
18. Messingham KA, Messingham KA, Shirazi M, et al. (2001) Testosterone receptor blockade restores cellular immunity in male mice after burn injury. J Endocrinol 169:299-308
19. Oberholzer A, Keel M, Zellweger R, et al. (2000) Incidence of septic complications and multiple organ failure in severely injured patients is sex specific. J Trauma 48:932-937
20. Offner PJ, Moore EE, Biffl WL (1999) Male gender is a risk factor for major infections after surgery. Arch Surg 134:935-938; discussion 938-940
21. Schroder J, Kahlke V, Staubach KH, et al. (1998) Gender differences in human sepsis. Arch Surg 133:1200-1205
22. Wichmann MW, Inthorn D, Andress HJ, et al. (2000) Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome. Intensive Care Med 26:167-172
23. Ben-Eliyahu S, Page GG, Yirmiya R, et al. (1996) Acute alcohol intoxication suppresses natural killer cell activity and promotes tumor metastasis. Nat Med 2:457-460
24. Bautista AP (2002) Chronic alcohol intoxication primes Kupffer cells and endothelial cells for enhanced CC-chemokine production and concomitantly suppresses phagocytosis and chemotaxis. Front Biosci 7:a117-a125
25. Jaruga B, Hong F, Kim WH, et al. (2004) Chronic alcohol consumption accelerates liver injury in T cell-mediated hepatitis: alcohol disregulation of NF-kappaB and STAT3 signaling pathways. Am J Physiol Gastrointest Liver Physiol 287:G471-G479
26. Valles SL, Blanco AM, Azorin I, et al. (2003) Chronic ethanol consumption enhances interleukin-1-mediated signal transduction in rat liver and in cultured hepatocytes. Alcohol Clin Exp Res 27:1979-1986
27. Chao DT, Korsmeyer SJ (1998) BCL-2 family: regulators of cell death. Annu Rev Immunol 16:395-419
28. Chu ZL, McKinsey TA, Liu L, et al. (1997) Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. Proc Natl Acad Sci U S A 94:10057-10062
29. Wang CY, Mayo MW, Korneluk RG, et al. (1998) NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281:1680-1683
30. Magne N, Toillon RA, Bottero V, et al. (2006) NF-kappaB modulation and ionizing radiation: mechanisms and future directions for cancer treatment. Cancer Lett 231:158-168
31. Wang CY, Guttridge DC, Mayo MW, et al. (1999) NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Mol Cell Biol 19:5923-5929
32. Mabuchi S, Ohmichi M, Nishio Y, et al. (2004) Inhibition of NFkappaB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models. J Biol Chem 279:23477-23485
33. Cusack JC Jr, Liu R, Houston M, et al. (2001) Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition. Cancer Res 61:3535-3540